Use of modified extracellular matrix proteins in diagnosis and treatment of… Grant US-8435532-B2 United States of America 07 May 2013
LR-9, LR-74 and LR-90 for use in treating complications resulting from diabetes Application EP-2269601-A1 European Patent Office 05 Jan 2011